Advertisement
Home »

Randomised, siteless study to compare systematic atrial fibrillation screening using enrichment by a risk prediction model with standard care in a Swedish population aged ≥ 65 years: CONSIDERING-AF study design.

Jan 15, 2024

ABOUT THE EXPERTS

  • Farzaneh Etminani

    Center for Applied Intelligent Systems Research in Health (CAISR Health), Halmstad University, Halmstad, Sweden farzaneh.etminani@hh.se.

    Department of Research and Development (FoU), Region Halland, Halmstad, Sweden.

    Emma Sandgren

    Department of Medicine, Hallands sjukhus Varberg, Varberg, Sweden.

    Johan Holm

    Pfizer AB, Stockholm, Sweden.

    Peter Magnusson

    Bristol Myers Squibb AB, Solna, Sweden.

    Angelo Modica

    Pfizer AB, Stockholm, Sweden.

    Karin Moberg

    SHAARPEC by Hallandia V, Stockholm, Sweden.

    Thomas Davidsson

    SHAARPEC by Hallandia V, Stockholm, Sweden.

    Linda Stalpe

    Bristol Myers Squibb AB, Solna, Sweden.

    Sara Kiflemariam

    Bristol Myers Squibb AB, Solna, Sweden.

    Ninia Younan

    Department of Medicine, Hallands sjukhus Varberg, Varberg, Sweden.

    Purvee Parikh

    Medical Affairs, Philips, Ambulatory Monitoring and Diagnostics, San Diego, California, USA.

    Manish Wadhwa

    Medical Affairs, Philips, Ambulatory Monitoring and Diagnostics, San Diego, California, USA.

    Anna Sundin

    Bristol Myers Squibb AB, Solna, Sweden.

    Johan Engdahl

    Department of Clinical Sciences, Karolinska Institutet, Danderyd University Hospital, Stockholm, Sweden.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement